MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202421027890 A) filed by BDR Pharmaceuticals International Private Limited, Maharashtra, on April 4, 2024, for 'pharmaceutical composition of relugolix tablet.'
Inventor(s) include Shah, Dharmesh Mahendrabhai; Badiger, Aravind Manappa; Upadhye, Abhijeet Ashokrao; Patel, Ketul Harshadbhai; Yadav, Sandeep Tarachand; Patil, Kishor Prakashrao; and Khatri, Kamal Rameshbhai.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to novel oral solid pharmaceutical formulation of relugolix or pharmaceutically acceptable salt there...